| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 30 | 2023 | 74 | 7.810 |
Why?
|
| Intestinal Mucosa | 39 | 2022 | 81 | 7.140 |
Why?
|
| Ethanol | 30 | 2020 | 47 | 6.640 |
Why?
|
| Circadian Rhythm | 20 | 2022 | 122 | 6.590 |
Why?
|
| Inflammatory Bowel Diseases | 21 | 2022 | 42 | 3.830 |
Why?
|
| Colon | 26 | 2020 | 57 | 3.810 |
Why?
|
| Parkinson Disease | 11 | 2023 | 314 | 3.330 |
Why?
|
| Intestines | 18 | 2021 | 33 | 2.890 |
Why?
|
| Animals | 62 | 2022 | 2092 | 2.660 |
Why?
|
| Colitis, Ulcerative | 14 | 2022 | 23 | 2.620 |
Why?
|
| Humans | 131 | 2023 | 12240 | 2.590 |
Why?
|
| Liver Diseases, Alcoholic | 10 | 2017 | 15 | 2.330 |
Why?
|
| Dysbiosis | 9 | 2023 | 22 | 2.120 |
Why?
|
| Male | 87 | 2022 | 6815 | 2.000 |
Why?
|
| Gastrointestinal Diseases | 5 | 2019 | 14 | 1.920 |
Why?
|
| Microbiota | 10 | 2023 | 35 | 1.730 |
Why?
|
| Gastrointestinal Tract | 7 | 2019 | 20 | 1.680 |
Why?
|
| Epithelial Cells | 8 | 2022 | 36 | 1.670 |
Why?
|
| Alcohol Drinking | 6 | 2020 | 28 | 1.510 |
Why?
|
| Inflammation | 10 | 2023 | 124 | 1.450 |
Why?
|
| Feces | 14 | 2023 | 40 | 1.450 |
Why?
|
| Permeability | 19 | 2022 | 48 | 1.430 |
Why?
|
| Oxidants | 10 | 2011 | 14 | 1.430 |
Why?
|
| Intestinal Absorption | 11 | 2017 | 15 | 1.400 |
Why?
|
| Epidermal Growth Factor | 8 | 2007 | 13 | 1.390 |
Why?
|
| Metabolic Syndrome | 2 | 2023 | 40 | 1.390 |
Why?
|
| Mice, Inbred C57BL | 19 | 2022 | 205 | 1.380 |
Why?
|
| Central Nervous System Depressants | 6 | 2019 | 11 | 1.360 |
Why?
|
| Mice | 25 | 2022 | 760 | 1.330 |
Why?
|
| Alcoholism | 10 | 2019 | 34 | 1.320 |
Why?
|
| Quality of Life | 5 | 2022 | 261 | 1.320 |
Why?
|
| Female | 57 | 2021 | 6974 | 1.280 |
Why?
|
| Liver | 6 | 2019 | 57 | 1.240 |
Why?
|
| Multiple System Atrophy | 2 | 2022 | 22 | 1.200 |
Why?
|
| Disease Models, Animal | 13 | 2020 | 338 | 1.170 |
Why?
|
| Bacteria | 8 | 2022 | 34 | 1.160 |
Why?
|
| Oxidative Stress | 14 | 2017 | 53 | 1.160 |
Why?
|
| Colon, Sigmoid | 4 | 2017 | 10 | 1.130 |
Why?
|
| Adult | 38 | 2021 | 3557 | 1.070 |
Why?
|
| Eating | 4 | 2021 | 25 | 1.060 |
Why?
|
| Cytoskeleton | 10 | 2007 | 21 | 1.020 |
Why?
|
| Middle Aged | 39 | 2021 | 4043 | 1.020 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2018 | 15 | 0.990 |
Why?
|
| Protein Kinase C | 5 | 2005 | 23 | 0.980 |
Why?
|
| Obesity | 4 | 2023 | 156 | 0.950 |
Why?
|
| NF-kappa B | 7 | 2022 | 53 | 0.920 |
Why?
|
| Photoperiod | 3 | 2016 | 14 | 0.900 |
Why?
|
| Circadian Clocks | 4 | 2022 | 12 | 0.900 |
Why?
|
| Colonic Neoplasms | 5 | 2014 | 28 | 0.860 |
Why?
|
| Fatty Acids, Volatile | 6 | 2021 | 10 | 0.860 |
Why?
|
| Caco-2 Cells | 17 | 2018 | 22 | 0.860 |
Why?
|
| Microtubules | 7 | 2003 | 18 | 0.840 |
Why?
|
| Time Factors | 13 | 2020 | 695 | 0.830 |
Why?
|
| Mast Cells | 4 | 2018 | 9 | 0.820 |
Why?
|
| Sleep Wake Disorders | 2 | 2018 | 58 | 0.800 |
Why?
|
| Stress, Psychological | 3 | 2022 | 112 | 0.800 |
Why?
|
| Mindfulness | 1 | 2022 | 19 | 0.740 |
Why?
|
| Crohn Disease | 6 | 2015 | 12 | 0.740 |
Why?
|
| CLOCK Proteins | 5 | 2018 | 9 | 0.730 |
Why?
|
| Actins | 5 | 2007 | 18 | 0.690 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2018 | 17 | 0.690 |
Why?
|
| Diarrhea | 5 | 2011 | 20 | 0.670 |
Why?
|
| Animal Husbandry | 1 | 2020 | 4 | 0.660 |
Why?
|
| Nitric Oxide | 3 | 2009 | 36 | 0.640 |
Why?
|
| Weight Gain | 1 | 2020 | 30 | 0.640 |
Why?
|
| Biomarkers | 8 | 2021 | 294 | 0.630 |
Why?
|
| alpha-Synuclein | 4 | 2017 | 59 | 0.630 |
Why?
|
| Work Schedule Tolerance | 1 | 2020 | 14 | 0.620 |
Why?
|
| Reactive Oxygen Species | 8 | 2011 | 55 | 0.620 |
Why?
|
| I-kappa B Proteins | 4 | 2007 | 6 | 0.620 |
Why?
|
| Signal Transduction | 7 | 2022 | 246 | 0.620 |
Why?
|
| Endotoxemia | 3 | 2015 | 5 | 0.620 |
Why?
|
| Transcription Factors | 2 | 2011 | 105 | 0.610 |
Why?
|
| Rotenone | 2 | 2018 | 5 | 0.610 |
Why?
|
| Chronobiology Disorders | 2 | 2017 | 4 | 0.600 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2019 | 2 | 0.600 |
Why?
|
| Neoplasms | 1 | 2020 | 94 | 0.600 |
Why?
|
| Mutation | 3 | 2018 | 175 | 0.590 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2019 | 4 | 0.580 |
Why?
|
| Antioxidants | 6 | 2006 | 34 | 0.570 |
Why?
|
| Depression | 2 | 2018 | 229 | 0.570 |
Why?
|
| Binge Drinking | 2 | 2019 | 6 | 0.570 |
Why?
|
| Light | 2 | 2016 | 36 | 0.560 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 9 | 0.560 |
Why?
|
| Macrophages | 1 | 2018 | 38 | 0.550 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 423 | 0.540 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2014 | 4 | 0.540 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2011 | 26 | 0.540 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 47 | 0.530 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 13 | 0.530 |
Why?
|
| Dietary Fiber | 6 | 2021 | 12 | 0.520 |
Why?
|
| Chromatography, Gas | 3 | 2015 | 8 | 0.520 |
Why?
|
| Rats | 14 | 2020 | 407 | 0.520 |
Why?
|
| MicroRNAs | 2 | 2014 | 20 | 0.510 |
Why?
|
| Sleep | 3 | 2021 | 155 | 0.500 |
Why?
|
| Cell Membrane Permeability | 4 | 2011 | 29 | 0.480 |
Why?
|
| Carbohydrates | 2 | 2021 | 4 | 0.480 |
Why?
|
| Immunity, Mucosal | 3 | 2017 | 4 | 0.470 |
Why?
|
| Period Circadian Proteins | 2 | 2017 | 3 | 0.470 |
Why?
|
| Food Hypersensitivity | 3 | 2021 | 17 | 0.470 |
Why?
|
| Brain | 5 | 2023 | 707 | 0.470 |
Why?
|
| Colitis | 6 | 2014 | 12 | 0.460 |
Why?
|
| Case-Control Studies | 7 | 2021 | 256 | 0.460 |
Why?
|
| Bacterial Translocation | 2 | 2014 | 10 | 0.460 |
Why?
|
| Melatonin | 1 | 2016 | 44 | 0.460 |
Why?
|
| Isoenzymes | 4 | 2005 | 28 | 0.450 |
Why?
|
| Sexuality | 1 | 2015 | 10 | 0.440 |
Why?
|
| Hydrogen Peroxide | 7 | 2007 | 21 | 0.440 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.440 |
Why?
|
| Urinalysis | 1 | 2015 | 7 | 0.440 |
Why?
|
| Body Image | 1 | 2015 | 19 | 0.440 |
Why?
|
| Infant, Premature | 1 | 2016 | 119 | 0.440 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 101 | 0.440 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 84 | 0.430 |
Why?
|
| Probiotics | 2 | 2018 | 8 | 0.430 |
Why?
|
| Hospitalization | 1 | 2016 | 158 | 0.420 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2019 | 28 | 0.410 |
Why?
|
| Mental Competency | 1 | 2013 | 8 | 0.400 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 128 | 0.400 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 125 | 0.400 |
Why?
|
| Gastrointestinal Motility | 7 | 2020 | 9 | 0.400 |
Why?
|
| Patient Participation | 1 | 2013 | 25 | 0.400 |
Why?
|
| Fatty Liver | 3 | 2019 | 13 | 0.400 |
Why?
|
| Aged | 16 | 2021 | 4000 | 0.390 |
Why?
|
| Diet | 5 | 2023 | 104 | 0.390 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 83 | 0.390 |
Why?
|
| Research Personnel | 1 | 2013 | 12 | 0.380 |
Why?
|
| Career Choice | 1 | 2013 | 13 | 0.380 |
Why?
|
| ErbB Receptors | 3 | 2009 | 31 | 0.380 |
Why?
|
| Type C Phospholipases | 2 | 2004 | 5 | 0.380 |
Why?
|
| Biomedical Research | 1 | 2013 | 27 | 0.380 |
Why?
|
| Models, Biological | 3 | 2010 | 191 | 0.380 |
Why?
|
| Butyrates | 3 | 2022 | 7 | 0.370 |
Why?
|
| Physicians | 1 | 2013 | 43 | 0.370 |
Why?
|
| Oligosaccharides | 3 | 2022 | 5 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 182 | 0.350 |
Why?
|
| Osteoarthritis | 3 | 2021 | 168 | 0.350 |
Why?
|
| Precancerous Conditions | 2 | 2018 | 11 | 0.350 |
Why?
|
| Young Adult | 5 | 2018 | 863 | 0.350 |
Why?
|
| Psychotherapy | 1 | 2011 | 19 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2011 | 225 | 0.350 |
Why?
|
| Wine | 1 | 2011 | 6 | 0.350 |
Why?
|
| Chronic Disease | 8 | 2018 | 186 | 0.340 |
Why?
|
| Body Mass Index | 3 | 2021 | 221 | 0.340 |
Why?
|
| Mice, Knockout | 5 | 2022 | 170 | 0.330 |
Why?
|
| HIV Infections | 4 | 2018 | 256 | 0.320 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 1 | 0.320 |
Why?
|
| Muscle, Smooth | 3 | 1995 | 5 | 0.310 |
Why?
|
| Wound Healing | 1 | 2010 | 55 | 0.310 |
Why?
|
| Dermatitis, Atopic | 2 | 2021 | 6 | 0.310 |
Why?
|
| Mesoderm | 1 | 2009 | 14 | 0.300 |
Why?
|
| Risk Factors | 7 | 2021 | 1049 | 0.300 |
Why?
|
| Mesalamine | 2 | 2008 | 2 | 0.300 |
Why?
|
| Immune System | 3 | 2021 | 6 | 0.300 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 16 | 0.300 |
Why?
|
| Phytotherapy | 2 | 2006 | 8 | 0.290 |
Why?
|
| Gastrointestinal Transit | 4 | 2012 | 7 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2006 | 39 | 0.290 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 101 | 0.290 |
Why?
|
| Gastroesophageal Reflux | 3 | 2004 | 17 | 0.280 |
Why?
|
| Dietary Supplements | 2 | 2021 | 26 | 0.280 |
Why?
|
| Healthy Volunteers | 3 | 2021 | 20 | 0.270 |
Why?
|
| Nitric Oxide Synthase | 3 | 2003 | 21 | 0.270 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2007 | 3 | 0.270 |
Why?
|
| Surveys and Questionnaires | 5 | 2021 | 546 | 0.270 |
Why?
|
| Hypnosis | 1 | 2007 | 1 | 0.270 |
Why?
|
| Colorectal Neoplasms | 2 | 2018 | 48 | 0.260 |
Why?
|
| Tight Junctions | 5 | 2022 | 8 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 195 | 0.260 |
Why?
|
| Jejunal Diseases | 2 | 2003 | 3 | 0.260 |
Why?
|
| Glucose | 2 | 2020 | 24 | 0.260 |
Why?
|
| Random Allocation | 2 | 2020 | 59 | 0.260 |
Why?
|
| Fatty Liver, Alcoholic | 2 | 2019 | 3 | 0.260 |
Why?
|
| Fermentation | 3 | 2021 | 4 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2007 | 40 | 0.250 |
Why?
|
| Graft vs Host Disease | 1 | 2007 | 31 | 0.250 |
Why?
|
| Cell Communication | 1 | 2007 | 14 | 0.250 |
Why?
|
| Metalloproteases | 1 | 2007 | 4 | 0.250 |
Why?
|
| Biopsy | 7 | 2018 | 97 | 0.250 |
Why?
|
| Nitrates | 3 | 2003 | 4 | 0.250 |
Why?
|
| Membrane Proteins | 3 | 2011 | 69 | 0.250 |
Why?
|
| Phosphorylation | 5 | 2005 | 78 | 0.250 |
Why?
|
| Gastrointestinal Agents | 3 | 2013 | 8 | 0.250 |
Why?
|
| Plant Preparations | 1 | 2006 | 3 | 0.250 |
Why?
|
| Intestinal Obstruction | 2 | 2003 | 9 | 0.240 |
Why?
|
| HIV-1 | 2 | 2018 | 143 | 0.240 |
Why?
|
| Neutrophils | 5 | 2002 | 58 | 0.240 |
Why?
|
| Enzyme Inhibitors | 5 | 2022 | 75 | 0.240 |
Why?
|
| Enterocolitis | 1 | 2006 | 3 | 0.240 |
Why?
|
| Disease Progression | 3 | 2022 | 290 | 0.240 |
Why?
|
| Mastocytosis, Systemic | 1 | 2006 | 6 | 0.240 |
Why?
|
| Calcium | 2 | 2001 | 288 | 0.230 |
Why?
|
| Blotting, Western | 5 | 2007 | 62 | 0.230 |
Why?
|
| Esophagitis | 2 | 2003 | 5 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2018 | 89 | 0.230 |
Why?
|
| Prevalence | 5 | 2018 | 175 | 0.230 |
Why?
|
| Endoscopy, Digestive System | 2 | 2003 | 5 | 0.220 |
Why?
|
| Starch | 2 | 2019 | 3 | 0.220 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 400 | 0.220 |
Why?
|
| Tubulin | 5 | 2003 | 10 | 0.220 |
Why?
|
| Esophagectomy | 1 | 2004 | 14 | 0.210 |
Why?
|
| Barrett Esophagus | 1 | 2004 | 10 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 22 | 0.210 |
Why?
|
| Gastric Bypass | 1 | 2004 | 26 | 0.210 |
Why?
|
| Leptin | 2 | 2022 | 11 | 0.210 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2012 | 10 | 0.210 |
Why?
|
| Free Radical Scavengers | 3 | 2017 | 4 | 0.200 |
Why?
|
| Enterocytes | 1 | 2003 | 1 | 0.200 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2003 | 1 | 0.200 |
Why?
|
| Intestinal Diseases | 1 | 2003 | 1 | 0.200 |
Why?
|
| Intestine, Small | 4 | 2012 | 19 | 0.200 |
Why?
|
| Administration, Oral | 3 | 2016 | 55 | 0.200 |
Why?
|
| Eosinophilia | 1 | 2003 | 13 | 0.200 |
Why?
|
| Transfection | 4 | 2004 | 59 | 0.200 |
Why?
|
| Central Nervous System | 1 | 2023 | 29 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2018 | 6 | 0.200 |
Why?
|
| Choristoma | 1 | 2003 | 2 | 0.190 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 31 | 0.190 |
Why?
|
| Cytosol | 4 | 2004 | 32 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 95 | 0.190 |
Why?
|
| Cytokines | 4 | 2017 | 107 | 0.190 |
Why?
|
| Digestive System | 2 | 2001 | 3 | 0.190 |
Why?
|
| Capillaries | 1 | 2002 | 3 | 0.190 |
Why?
|
| Luminescent Measurements | 6 | 2003 | 8 | 0.180 |
Why?
|
| Vasculitis | 1 | 2002 | 17 | 0.180 |
Why?
|
| Osteogenesis | 1 | 2022 | 84 | 0.180 |
Why?
|
| Infant | 3 | 2021 | 277 | 0.180 |
Why?
|
| Choline | 1 | 2022 | 2 | 0.180 |
Why?
|
| Esophagus | 4 | 2003 | 33 | 0.180 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Food | 2 | 2020 | 15 | 0.180 |
Why?
|
| Avena | 1 | 2001 | 1 | 0.180 |
Why?
|
| Carcinogenesis | 2 | 2018 | 11 | 0.170 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 16 | 0.170 |
Why?
|
| Pancreas | 2 | 2018 | 16 | 0.170 |
Why?
|
| Aging | 2 | 2018 | 680 | 0.170 |
Why?
|
| Colonic Diseases, Functional | 1 | 2001 | 1 | 0.170 |
Why?
|
| Life Style | 1 | 2022 | 102 | 0.170 |
Why?
|
| Proctitis | 1 | 2001 | 3 | 0.170 |
Why?
|
| Milk | 1 | 2021 | 5 | 0.170 |
Why?
|
| Vitamin E | 1 | 2001 | 23 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2021 | 21 | 0.170 |
Why?
|
| Ascorbic Acid | 1 | 2001 | 25 | 0.170 |
Why?
|
| Radiation Injuries | 1 | 2001 | 15 | 0.170 |
Why?
|
| Retrospective Studies | 7 | 2016 | 1467 | 0.170 |
Why?
|
| Dietary Sucrose | 2 | 2014 | 5 | 0.170 |
Why?
|
| Cadherins | 1 | 2020 | 13 | 0.160 |
Why?
|
| Clostridium | 1 | 2020 | 1 | 0.160 |
Why?
|
| Transaminases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Bone Density | 1 | 2021 | 110 | 0.160 |
Why?
|
| Levodopa | 1 | 2020 | 14 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 60 | 0.160 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 97 | 0.160 |
Why?
|
| Gastric Emptying | 3 | 1991 | 4 | 0.160 |
Why?
|
| Antiparkinson Agents | 1 | 2020 | 18 | 0.160 |
Why?
|
| Snail Family Transcription Factors | 2 | 2011 | 3 | 0.160 |
Why?
|
| Respiratory Burst | 2 | 2002 | 15 | 0.160 |
Why?
|
| Insulin | 1 | 2020 | 41 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 24 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 53 | 0.160 |
Why?
|
| Macaca mulatta | 1 | 2020 | 25 | 0.160 |
Why?
|
| Colonic Diseases | 1 | 2000 | 2 | 0.160 |
Why?
|
| Esophageal Achalasia | 2 | 2004 | 9 | 0.160 |
Why?
|
| Constipation | 3 | 2016 | 6 | 0.160 |
Why?
|
| Immunosuppressive Agents | 3 | 2007 | 61 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2018 | 1478 | 0.160 |
Why?
|
| Microglia | 1 | 2020 | 64 | 0.150 |
Why?
|
| Metagenome | 3 | 2023 | 6 | 0.150 |
Why?
|
| Osteolysis | 1 | 2020 | 66 | 0.150 |
Why?
|
| Growth Substances | 1 | 1999 | 20 | 0.150 |
Why?
|
| Cats | 4 | 1995 | 15 | 0.150 |
Why?
|
| Reoperation | 1 | 2021 | 366 | 0.150 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 92 | 0.150 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 22 | 0.150 |
Why?
|
| Adolescent | 5 | 2018 | 989 | 0.150 |
Why?
|
| Diet, High-Fat | 2 | 2022 | 8 | 0.150 |
Why?
|
| DNA Damage | 1 | 2019 | 14 | 0.150 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2017 | 6 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2019 | 21 | 0.150 |
Why?
|
| Chronotherapy | 1 | 2019 | 2 | 0.150 |
Why?
|
| Biodiversity | 1 | 2019 | 16 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 45 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 98 | 0.150 |
Why?
|
| Parkinsonian Disorders | 1 | 2020 | 91 | 0.150 |
Why?
|
| Interleukin-8 | 1 | 1999 | 13 | 0.150 |
Why?
|
| Firmicutes | 1 | 2019 | 5 | 0.140 |
Why?
|
| CD3 Complex | 1 | 2018 | 2 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 23 | 0.140 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 4 | 0.140 |
Why?
|
| Lectins | 1 | 2018 | 3 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2019 | 20 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 57 | 0.140 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 46 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2018 | 28 | 0.140 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 3 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 6 | 0.140 |
Why?
|
| Muscle Contraction | 2 | 1995 | 52 | 0.140 |
Why?
|
| Lactulose | 4 | 2011 | 5 | 0.140 |
Why?
|
| Mice, SCID | 1 | 2018 | 24 | 0.140 |
Why?
|
| Prebiotics | 1 | 2018 | 3 | 0.140 |
Why?
|
| Perception | 1 | 2018 | 42 | 0.140 |
Why?
|
| DNA | 2 | 2017 | 57 | 0.140 |
Why?
|
| Glutathione | 1 | 1998 | 18 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 11 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2018 | 41 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2018 | 90 | 0.140 |
Why?
|
| Anxiety | 1 | 2018 | 73 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 4 | 0.140 |
Why?
|
| Spinal Cord Injuries | 2 | 1995 | 17 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 13 | 0.130 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 11 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2017 | 275 | 0.130 |
Why?
|
| Oxidation-Reduction | 5 | 2005 | 33 | 0.130 |
Why?
|
| Saliva | 1 | 2018 | 24 | 0.130 |
Why?
|
| Protein Kinases | 1 | 2017 | 6 | 0.130 |
Why?
|
| Animal Feed | 1 | 2017 | 1 | 0.130 |
Why?
|
| Kidney | 1 | 2018 | 87 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 83 | 0.130 |
Why?
|
| Methamphetamine | 1 | 2018 | 16 | 0.130 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 5 | 0.130 |
Why?
|
| Kinetics | 2 | 2015 | 110 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 29 | 0.130 |
Why?
|
| Analgesics | 1 | 2018 | 48 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 6 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 46 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2017 | 40 | 0.130 |
Why?
|
| Kupffer Cells | 1 | 2017 | 2 | 0.130 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 20 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2017 | 6 | 0.130 |
Why?
|
| Candida | 1 | 2017 | 9 | 0.130 |
Why?
|
| Arthralgia | 1 | 2018 | 56 | 0.130 |
Why?
|
| Fish Oils | 1 | 2017 | 1 | 0.130 |
Why?
|
| Uridine | 1 | 2017 | 1 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2003 | 28 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2009 | 7 | 0.130 |
Why?
|
| Sinusitis | 1 | 2018 | 66 | 0.130 |
Why?
|
| Microscopy, Confocal | 3 | 2003 | 51 | 0.130 |
Why?
|
| Mannitol | 3 | 2011 | 9 | 0.120 |
Why?
|
| Mitomycin | 2 | 1996 | 5 | 0.120 |
Why?
|
| Milk, Human | 1 | 2018 | 91 | 0.120 |
Why?
|
| Hydroxyurea | 1 | 1996 | 10 | 0.120 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1996 | 5 | 0.120 |
Why?
|
| Methane | 1 | 2016 | 2 | 0.120 |
Why?
|
| Diverticulum | 1 | 2016 | 3 | 0.120 |
Why?
|
| Gastric Mucosa | 3 | 2003 | 5 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 2152 | 0.120 |
Why?
|
| Esophagogastric Junction | 2 | 1995 | 4 | 0.120 |
Why?
|
| Photic Stimulation | 1 | 2016 | 11 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 15 | 0.120 |
Why?
|
| Granulocytes | 2 | 1986 | 6 | 0.120 |
Why?
|
| Apoptosis | 3 | 2007 | 105 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 41 | 0.120 |
Why?
|
| Birth Weight | 1 | 2016 | 28 | 0.120 |
Why?
|
| Blood Cells | 1 | 1995 | 2 | 0.120 |
Why?
|
| Phylogeny | 1 | 2016 | 35 | 0.120 |
Why?
|
| Neural Inhibition | 1 | 1995 | 7 | 0.120 |
Why?
|
| Gestational Age | 1 | 2016 | 52 | 0.120 |
Why?
|
| Resins, Synthetic | 1 | 1995 | 1 | 0.110 |
Why?
|
| Sucrose | 2 | 2011 | 4 | 0.110 |
Why?
|
| Indium Radioisotopes | 1 | 1995 | 4 | 0.110 |
Why?
|
| Protein Folding | 1 | 2015 | 10 | 0.110 |
Why?
|
| Cell Line | 2 | 2009 | 150 | 0.110 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 10 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 6 | 0.110 |
Why?
|
| Joints | 1 | 2015 | 43 | 0.110 |
Why?
|
| Stomach | 1 | 1994 | 7 | 0.110 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 3 | 0.110 |
Why?
|
| Hepatitis B | 1 | 2014 | 6 | 0.110 |
Why?
|
| Hippocampus | 1 | 2015 | 97 | 0.110 |
Why?
|
| Vaccination | 1 | 2014 | 9 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2016 | 312 | 0.110 |
Why?
|
| Gastrointestinal Absorption | 1 | 2014 | 1 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2005 | 22 | 0.110 |
Why?
|
| Polyradiculoneuropathy | 1 | 1994 | 2 | 0.110 |
Why?
|
| Colonoscopy | 3 | 2016 | 36 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 24 | 0.110 |
Why?
|
| Esophageal Motility Disorders | 2 | 1993 | 2 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 1994 | 20 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2023 | 827 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2015 | 64 | 0.100 |
Why?
|
| Smoking | 1 | 2015 | 84 | 0.100 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 1 | 0.100 |
Why?
|
| Child | 4 | 2021 | 614 | 0.100 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2007 | 4 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 68 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 651 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 37 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2004 | 42 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 2 | 2003 | 4 | 0.100 |
Why?
|
| Serine | 2 | 2003 | 6 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 76 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 61 | 0.100 |
Why?
|
| Biota | 1 | 2013 | 4 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 42 | 0.100 |
Why?
|
| Liver Function Tests | 2 | 2004 | 12 | 0.100 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 163 | 0.100 |
Why?
|
| Social Support | 1 | 2013 | 98 | 0.100 |
Why?
|
| Amifostine | 1 | 1992 | 2 | 0.100 |
Why?
|
| Catalase | 1 | 1992 | 3 | 0.090 |
Why?
|
| Salicylates | 1 | 1992 | 3 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 34 | 0.090 |
Why?
|
| Phospholipase C gamma | 2 | 2004 | 6 | 0.090 |
Why?
|
| Capsule Endoscopy | 1 | 2012 | 4 | 0.090 |
Why?
|
| Protein Kinase C beta | 2 | 2003 | 3 | 0.090 |
Why?
|
| Cell Movement | 2 | 2009 | 42 | 0.090 |
Why?
|
| Receptors, Cholinergic | 1 | 1992 | 14 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 1992 | 1 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 1992 | 6 | 0.090 |
Why?
|
| Cholecystectomy | 1 | 1991 | 3 | 0.090 |
Why?
|
| Cholelithiasis | 1 | 1991 | 3 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 68 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 1991 | 14 | 0.090 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 3 | 0.090 |
Why?
|
| Rectum | 3 | 2002 | 21 | 0.090 |
Why?
|
| Enteric Nervous System | 1 | 2011 | 3 | 0.090 |
Why?
|
| Esophagitis, Peptic | 1 | 1991 | 1 | 0.090 |
Why?
|
| Endotoxins | 2 | 2001 | 3 | 0.090 |
Why?
|
| Lysine | 1 | 2011 | 3 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 54 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2011 | 13 | 0.080 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 5 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2001 | 64 | 0.080 |
Why?
|
| Rats, Inbred F344 | 3 | 2018 | 22 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2010 | 3 | 0.080 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 2 | 0.080 |
Why?
|
| Anastomotic Leak | 1 | 2010 | 2 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 17 | 0.080 |
Why?
|
| Breath Tests | 4 | 2016 | 5 | 0.080 |
Why?
|
| Antibodies | 1 | 2010 | 25 | 0.080 |
Why?
|
| Deficiency Diseases | 1 | 2010 | 1 | 0.080 |
Why?
|
| Neurons | 1 | 2011 | 164 | 0.080 |
Why?
|
| Microspheres | 1 | 2009 | 12 | 0.080 |
Why?
|
| Deglutition Disorders | 2 | 2003 | 15 | 0.080 |
Why?
|
| Catheterization | 2 | 2003 | 23 | 0.080 |
Why?
|
| Gastrostomy | 1 | 1989 | 3 | 0.080 |
Why?
|
| Cell Count | 2 | 2007 | 38 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1989 | 7 | 0.080 |
Why?
|
| Indium | 2 | 1986 | 3 | 0.070 |
Why?
|
| Radioisotopes | 2 | 1986 | 3 | 0.070 |
Why?
|
| Body Weight | 3 | 2008 | 72 | 0.070 |
Why?
|
| Biological Availability | 1 | 2008 | 8 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2001 | 19 | 0.070 |
Why?
|
| Malabsorption Syndromes | 1 | 1988 | 1 | 0.070 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1988 | 1 | 0.070 |
Why?
|
| Amylases | 1 | 1988 | 3 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 1988 | 8 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 29 | 0.070 |
Why?
|
| Metabolomics | 2 | 2021 | 6 | 0.070 |
Why?
|
| Age Factors | 2 | 2021 | 350 | 0.070 |
Why?
|
| Prognosis | 2 | 2007 | 363 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2007 | 4 | 0.070 |
Why?
|
| Transplantation Conditioning | 1 | 2007 | 18 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2007 | 20 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 214 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2017 | 25 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 10 | 0.070 |
Why?
|
| Viral Load | 2 | 2017 | 43 | 0.070 |
Why?
|
| Acute Disease | 1 | 2007 | 90 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2007 | 113 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 63 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 93 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2007 | 3 | 0.060 |
Why?
|
| Cattle | 1 | 2007 | 54 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 55 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 5 | 0.060 |
Why?
|
| ADAM17 Protein | 1 | 2007 | 2 | 0.060 |
Why?
|
| Intercellular Junctions | 1 | 2007 | 6 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 43 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 20 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 15 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 23 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 13 | 0.060 |
Why?
|
| ADAM Proteins | 1 | 2007 | 18 | 0.060 |
Why?
|
| Laparoscopy | 2 | 2004 | 95 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2007 | 57 | 0.060 |
Why?
|
| Herbal Medicine | 1 | 2006 | 4 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 73 | 0.060 |
Why?
|
| Cell Death | 2 | 2011 | 22 | 0.060 |
Why?
|
| Lactose Intolerance | 1 | 1986 | 1 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2006 | 20 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2006 | 18 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2006 | 13 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 10 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 10 | 0.060 |
Why?
|
| Ranitidine | 1 | 2006 | 3 | 0.060 |
Why?
|
| Cetirizine | 1 | 2006 | 3 | 0.060 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 3 | 0.060 |
Why?
|
| Tryptases | 1 | 2006 | 3 | 0.060 |
Why?
|
| Duodenum | 1 | 2006 | 5 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 1986 | 11 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 11 | 0.060 |
Why?
|
| Homeostasis | 2 | 2017 | 35 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 100 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 151 | 0.060 |
Why?
|
| Radionuclide Imaging | 3 | 1995 | 21 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2005 | 81 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 12 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 6 | 0.060 |
Why?
|
| Protein Kinase C-theta | 1 | 2005 | 1 | 0.060 |
Why?
|
| Claudin-4 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Claudin-1 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Asthma | 1 | 2006 | 76 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 18 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2005 | 7 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 132 | 0.050 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2004 | 4 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2004 | 10 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2004 | 105 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2015 | 18 | 0.050 |
Why?
|
| United States | 1 | 2007 | 989 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2004 | 3 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 5 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 8 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 196 | 0.050 |
Why?
|
| Fundoplication | 1 | 2004 | 12 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1995 | 179 | 0.050 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 2 | 0.050 |
Why?
|
| Budesonide | 1 | 2003 | 2 | 0.050 |
Why?
|
| Azathioprine | 1 | 2003 | 3 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2003 | 3 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 3 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2003 | 9 | 0.050 |
Why?
|
| Esophageal Perforation | 1 | 2003 | 7 | 0.050 |
Why?
|
| Proton Pumps | 1 | 2003 | 10 | 0.050 |
Why?
|
| Ileostomy | 1 | 1983 | 1 | 0.050 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1983 | 1 | 0.050 |
Why?
|
| Eosinophils | 1 | 2003 | 15 | 0.050 |
Why?
|
| Indomethacin | 1 | 1983 | 2 | 0.050 |
Why?
|
| Prednisone | 1 | 2003 | 31 | 0.050 |
Why?
|
| Metronidazole | 1 | 1983 | 4 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2005 | 29 | 0.050 |
Why?
|
| Manometry | 3 | 1996 | 7 | 0.050 |
Why?
|
| Recurrence | 1 | 2003 | 126 | 0.050 |
Why?
|
| Cell Survival | 2 | 2001 | 46 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 12 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 151 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 117 | 0.050 |
Why?
|
| Laparotomy | 1 | 2003 | 9 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 252 | 0.050 |
Why?
|
| Fluorometry | 1 | 2003 | 3 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 4 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 5 | 0.050 |
Why?
|
| Peroxidase | 2 | 2008 | 6 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 28 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 6 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2004 | 142 | 0.050 |
Why?
|
| Luminol | 2 | 1992 | 2 | 0.050 |
Why?
|
| Quinolones | 1 | 2002 | 6 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 50 | 0.050 |
Why?
|
| Alanine | 1 | 2002 | 7 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 281 | 0.040 |
Why?
|
| Methylamines | 1 | 2022 | 2 | 0.040 |
Why?
|
| Lyases | 1 | 2022 | 4 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 47 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 7 | 0.040 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2021 | 10 | 0.040 |
Why?
|
| Metalloporphyrins | 1 | 2001 | 2 | 0.040 |
Why?
|
| Amino Acids | 1 | 2001 | 8 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2002 | 49 | 0.040 |
Why?
|
| Acupuncture Therapy | 1 | 2001 | 1 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 86 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 726 | 0.040 |
Why?
|
| Glycomics | 1 | 2021 | 1 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2021 | 2 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Central Nervous System Agents | 1 | 2001 | 6 | 0.040 |
Why?
|
| Hypochlorous Acid | 1 | 2001 | 1 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2001 | 6 | 0.040 |
Why?
|
| Calcimycin | 1 | 2001 | 3 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 1 | 2001 | 6 | 0.040 |
Why?
|
| Maleimides | 1 | 2001 | 3 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 2 | 0.040 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 3 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 3 | 0.040 |
Why?
|
| Complement Activation | 1 | 2021 | 4 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 9 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2001 | 16 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 88 | 0.040 |
Why?
|
| Pasteurization | 1 | 2021 | 1 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2021 | 12 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 193 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 69 | 0.040 |
Why?
|
| Indoles | 1 | 2001 | 21 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 11 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 11 | 0.040 |
Why?
|
| Remission Induction | 1 | 2001 | 45 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 157 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2021 | 51 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2001 | 63 | 0.040 |
Why?
|
| Deamination | 1 | 2020 | 1 | 0.040 |
Why?
|
| Superoxides | 1 | 2000 | 9 | 0.040 |
Why?
|
| Anilides | 1 | 2020 | 3 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 4 | 0.040 |
Why?
|
| Neurotoxins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 20 | 0.040 |
Why?
|
| Fluorescence | 1 | 2000 | 5 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 32 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 36 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 126 | 0.040 |
Why?
|
| Colchicine | 1 | 2000 | 6 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2000 | 25 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2021 | 229 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 324 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 800 | 0.040 |
Why?
|
| Algorithms | 2 | 2015 | 169 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 207 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 6 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 23 | 0.040 |
Why?
|
| Triglycerides | 1 | 2019 | 24 | 0.040 |
Why?
|
| Dialysis Solutions | 1 | 1999 | 2 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1999 | 3 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 3 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 5 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2021 | 248 | 0.040 |
Why?
|
| Solanum tuberosum | 1 | 2019 | 2 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 1999 | 49 | 0.040 |
Why?
|
| Particle Size | 2 | 2011 | 18 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2021 | 817 | 0.040 |
Why?
|
| Proteins | 1 | 1999 | 33 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2018 | 3 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 18 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 12 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 19 | 0.040 |
Why?
|
| Tyrosine | 2 | 2011 | 10 | 0.040 |
Why?
|
| Costimulatory and Inhibitory T-Cell Receptors | 1 | 2018 | 2 | 0.030 |
Why?
|
| Acetic Acid | 2 | 2001 | 2 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 1998 | 1 | 0.030 |
Why?
|
| Bone Development | 1 | 2018 | 23 | 0.030 |
Why?
|
| Protective Agents | 1 | 2018 | 3 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 6 | 0.030 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 6 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 464 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 143 | 0.030 |
Why?
|
| Self Administration | 1 | 2018 | 9 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 14 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 2 | 0.030 |
Why?
|
| Ileum | 1 | 2017 | 6 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2018 | 33 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 33 | 0.030 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2017 | 1 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2017 | 7 | 0.030 |
Why?
|
| South Africa | 1 | 2017 | 3 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 12 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 349 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 169 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 6 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 338 | 0.030 |
Why?
|
| Diverticulum, Colon | 1 | 1996 | 1 | 0.030 |
Why?
|
| Colectomy | 1 | 1996 | 10 | 0.030 |
Why?
|
| Colonic Polyps | 1 | 1996 | 14 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 1996 | 1 | 0.030 |
Why?
|
| Celiac Disease | 1 | 2016 | 3 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1996 | 35 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 320 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 15 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1995 | 5 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 11 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 171 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 641 | 0.030 |
Why?
|
| Reference Values | 1 | 1995 | 103 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 85 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2015 | 59 | 0.030 |
Why?
|
| Support Vector Machine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1994 | 12 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 4 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 6 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 3 | 0.030 |
Why?
|
| Carbachol | 1 | 1994 | 2 | 0.030 |
Why?
|
| Herpesvirus 3, Human | 1 | 1994 | 2 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 26 | 0.030 |
Why?
|
| Biological Transport | 1 | 1994 | 23 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1994 | 125 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2014 | 9 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 36 | 0.030 |
Why?
|
| Temperance | 1 | 1994 | 1 | 0.030 |
Why?
|
| Genes, APC | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2014 | 1 | 0.030 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 3 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 218 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 71 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2014 | 15 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 39 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 16 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 39 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2013 | 4 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2013 | 9 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2013 | 28 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 115 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 8 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 453 | 0.020 |
Why?
|
| Acetates | 1 | 1992 | 9 | 0.020 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1992 | 1 | 0.020 |
Why?
|
| Bethanechol | 1 | 1992 | 3 | 0.020 |
Why?
|
| Atropine | 1 | 1992 | 2 | 0.020 |
Why?
|
| Bethanechol Compounds | 1 | 1992 | 3 | 0.020 |
Why?
|
| Pirenzepine | 1 | 1992 | 3 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1992 | 14 | 0.020 |
Why?
|
| Anti-Ulcer Agents | 1 | 1992 | 1 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 56 | 0.020 |
Why?
|
| Gastric Acid | 1 | 1992 | 3 | 0.020 |
Why?
|
| District of Columbia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Occludin | 1 | 2011 | 4 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2011 | 20 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 13 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 34 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1991 | 141 | 0.020 |
Why?
|
| Air Pollution | 1 | 2011 | 13 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2011 | 48 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 35 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2011 | 68 | 0.020 |
Why?
|
| Alcoholic Intoxication | 1 | 1990 | 4 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 31 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 4 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 38 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2008 | 1 | 0.020 |
Why?
|
| Environment | 1 | 2008 | 19 | 0.020 |
Why?
|
| Chemotactic Factors | 1 | 1988 | 1 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1988 | 6 | 0.020 |
Why?
|
| Lysosomes | 1 | 1988 | 13 | 0.020 |
Why?
|
| Nutrition Disorders | 1 | 1987 | 3 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1986 | 4 | 0.020 |
Why?
|
| Digestion | 1 | 1986 | 1 | 0.020 |
Why?
|
| Hydrogen | 1 | 1986 | 1 | 0.020 |
Why?
|
| Nausea | 1 | 1986 | 16 | 0.020 |
Why?
|
| Vomiting | 1 | 1986 | 14 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1986 | 3 | 0.010 |
Why?
|
| Tropolone | 1 | 1986 | 1 | 0.010 |
Why?
|
| Intestinal Perforation | 1 | 1986 | 2 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2006 | 23 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1986 | 10 | 0.010 |
Why?
|
| Autoradiography | 1 | 1985 | 5 | 0.010 |
Why?
|
| Cholestasis | 1 | 1985 | 4 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1985 | 11 | 0.010 |
Why?
|
| Excipients | 1 | 2005 | 1 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2005 | 2 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2005 | 3 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 2005 | 9 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 18 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1985 | 11 | 0.010 |
Why?
|
| Polymers | 1 | 2005 | 16 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2005 | 24 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 60 | 0.010 |
Why?
|
| Nucleic Acids | 1 | 2005 | 1 | 0.010 |
Why?
|
| Nucleosides | 1 | 2005 | 1 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 2005 | 2 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 3 | 0.010 |
Why?
|
| Aldehydes | 1 | 2005 | 2 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 6 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 12 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 14 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 233 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1986 | 385 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2001 | 2 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2001 | 10 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2001 | 8 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2001 | 18 | 0.010 |
Why?
|
| Portal System | 1 | 2000 | 1 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2000 | 3 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2000 | 9 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 8 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 14 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 29 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 1 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1999 | 1 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1996 | 118 | 0.010 |
Why?
|
| Peristalsis | 1 | 1993 | 4 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 3 | 0.000 |
Why?
|
| Biological Assay | 1 | 1988 | 3 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1988 | 10 | 0.000 |
Why?
|
| Bacteriological Techniques | 1 | 1988 | 5 | 0.000 |
Why?
|
| Radiography | 1 | 1985 | 258 | 0.000 |
Why?
|